Interplay Between Dyslipidemia, Atherogenic Lipoproteins, and Residual Atherogenic Risk in Liver Transplant Recipients

Clin Gastroenterol Hepatol. 2023 Jun;21(6):1660-1662.e1. doi: 10.1016/j.cgh.2022.04.022. Epub 2022 May 6.

Liver Transplant Biomarker Group:
Sean Flynn¹, Taseen Syed⁵, Ramzi Hassouneh¹, Vaishali Patel⁵, Amon Asgharpour⁵, Mark Muthiah⁶

¹ Department of Internal Medicine, Virginia Commonwealth University Health Systems, Richmond, Virginia.
² Laboratory Corporation of America® Holdings (Labcorp), Morrisville, North Carolina.
³ Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia.
⁴ Division of Gastroenterology, Hepatology, and Nutrition, Section of Hepatology, Virginia Commonwealth University Health Systems, Richmond, Virginia.
⁵ Division of Gastroenterology, Hepatology and Nutrition, Section of Hepatology, Virginia Commonwealth University Health Systems, Richmond, Virginia.
⁶ National University, Singapore.

No abstract available

Publication types